The interferons and their inducers: molecular and therapeutic considerations. 3.
D000818:Animals; D001419:Bacteria / Q000187:drug effects; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D002478:Cells, Cultured; D004247:DNA / Q000096:biosynthesis; D056890:Eukaryota / Q000187:drug effects; D006801:Humans; D007111:Immunity, Cellular; D007239:Infections / Q000188:drug therapy; D007372:Interferons / Q000096:biosynthesis / Q000494:pharmacology / Q000627:therapeutic use; D051379:Mice; D012157:Mononuclear Phagocyte System / Q000276:immunology; D009369:Neoplasms / Q000188:drug therapy; D009858:Oncogenic Viruses / Q000187:drug effects; D011108:Polymers / Q000627:therapeutic use; D011134:Polysaccharides / Q000627:therapeutic use; D011714:Pyrans / Q000627:therapeutic use; D014777:Virus Diseases / Q000276:immunology; D014779:Virus Replication
D011108:Polymers; D011134:Polysaccharides; D011714:Pyrans; D004247:DNA; D007372:Interferons